PHARMACOECONOMIC AND DRUG UTILIZATION STUDY OF ANTIDIABETIC THERAPY IN A TERTIARY CARE TEACHING HOSPITAL OF NORTHERN INDIA

Authors

  • Afroz Abidi Associate Professor, PHARMACOLOGY, Era's Lucknow Medical College, Lucknow, U.P
  • Dilshad Ali Rizvi Associate Professor, PHARMACOLOGY, Era's Lucknow Medical College, Lucknow, U.P
  • Ali Ahmad Professor, PHARMACOLOGY, Era's Lucknow Medical College, Lucknow, U.P

Abstract

Objective: This study was planned to analyze the prescription patterns and compare the cost of antidiabetic drugs in our tertiary care teaching
hospital.
Methods: It was a prospective observational study conducted over a period of 6-month. Data were collected on a predesigned case record form from
patients of diabetes attending medicine outpatient department, and the core prescribing indicators were evaluated. Their pharmacy bill was also
collected and analyzed and percentage variation in the cost of antidiabetic drugs was calculated.
Results: A total of 262 prescriptions were analyzed showing the main age group between 50 and 60 years (39.69%). Out of 262 patients, 141 (53.82%)
were males and 121 (46.18%) were females. 176 (67.17%) prescriptions had 2-5 drugs showing clear evidence of polypharmacy. The total number
of drugs prescribed in 262 prescriptions were 1209, and thus, an average number of drugs prescribed were 4.61/prescription. The most common
antidiabetic drug prescribed was metformin 500 mg in 189 (33.99%) patients, and the most common antidiabetic combination was glimepiride 2 mg
+ metformin 500 mg in 62 (34.63%) patients. Insulin was used in 37 (14.12%) prescriptions. Among other drugs, maximally used were atorvastatin
86 (7.11%) followed by aspirin 54 (4.46%) patients. The percentage cost difference of antidiabetic drugs varies from 40.62 to 633.33. The cost of
monthly therapy for a maximum number of patients was in the cost range INR 100-500 in 148 (56.48%) patients.
Conclusion: The most frequently prescribed antidiabetic drug was metformin and the most frequently used combination used was glimepiride and
metformin. Polypharmacy was also evident in our study, and the cost of monthly antidiabetic therapy was also moderately high.
Keywords: Pharmacoeconomic, Drug utilization, Antidiabetic drugs.

Downloads

Download data is not yet available.

Author Biographies

Afroz Abidi, Associate Professor, PHARMACOLOGY, Era's Lucknow Medical College, Lucknow, U.P

Associate Professor, PHARMACOLOGY, Era's Lucknow Medical College, Lucknow, U.P

Dilshad Ali Rizvi, Associate Professor, PHARMACOLOGY, Era's Lucknow Medical College, Lucknow, U.P

Associate Professor, PHARMACOLOGY, Era's Lucknow Medical College, Lucknow, U.P

Ali Ahmad, Professor, PHARMACOLOGY, Era's Lucknow Medical College, Lucknow, U.P

Professor, PHARMACOLOGY, Era's Lucknow Medical College, Lucknow, U.P

References

Definition and Diagnosis of Diabetes Mellitus and Intermediate

Hyperglycemia. Available from: http://www.who.int/diabetes/

publications. [Last accessed on 2016 Feb 25].

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of

diabetes: Estimates for the year 2000 and projections for 2030. Diabetes

Care 2004;27(5):1047-53.

Diabetes and South Asians. Available from: http://www.

indianheartassociation.org/why-indians-why-south-asians/overview/.

[Last accessed on 2016 Feb 25].

Zaveri HG, Mansuri SM, Patel VJ. Use of potentially inappropriate

medicines in elderly: A prospective study in medicine out-patient

department of a tertiary care teaching hospital. Indian J Pharmacol

;42(2):95-8.

Essential Medicines and Health Products. Available from: http://

www.who.int/medicines/areas/rational_use/en/. [Last accessed on

Feb 29].

Gama H. Drug utilization studies. Arq Med 2008;22:69-74.

How to Investigate Drug Use in Health Facilities: Selected Drug Use

Indicators - EDM Research Series No. 007. Available from: http://

ww.apps.who.int/medicinedocs/en/d/Js2289e/3.1.html. [Last accessed

on 2016 Feb 29].

Fox Rushby J, Cairns J. Economic Evaluation. Maidenhead: Open

University Press; 2005.

Ahuja J, Gupta M, Gupta AK, Kohli K. Pharmacoeconomics. Natl Med

J India 2004;17:80-3.

Acharya KG, Shah KN, Solanki ND, Rana DA. Evaluation of

antidiabetic prescriptions, cost and adherence to treatment guidelines:

A prospective, cross-sectional study at a tertiary care teaching hospital.

J Basic Clin Pharm 2013;4(4):82-7.

Das P, Das BP, Rauniar GP, Roy RK, Sharma SK. Drug utilization

pattern and effectiveness analysis in diabetes mellitus at a

tertiary care centre in eastern Nepal. Indian J Physiol Pharmacol

;55:272-80.

Abdi SA, Churi S, Kumar YS. Study of drug utilization pattern of

antihyperglycemic agents in a South Indian tertiary care teaching

hospital. Indian J Pharmacol 2012;44(2):210-4.

Assefa B, Wondimu A, Abrha S, Dinda SC, Demeke B, GebreSamuel

N,

et

al.

Pharmacoeconomic

evaluation

of

antidiabetic

treatment

at

Ayder

Referral

Hospital,

Mekelle,

Ethiopia.

Int

J

Pharm

Sci

Rev Res 2014;25(1):47-52.

Rataboli PV, Dang A. Antimicrobial price variation: Conundrum of

medical profession! J Postgrad Med 2007;53(1):72-4.

de Pablos-Velasco PL, Martínez-Martín FJ, Molero R, RodríguezPerez

F,

García-Puente

I,

Caballero

A.

Patterns of

prescription

of

hypoglycaemic

drugs

in Gran Canaria

(Canary islands, Spain) and

estimation

of

the prevalence

of

diabetes mellitus.

Diabetes

Metab

;31(5):457-62.

Kannan, Arshad, Kumar S. A study on drug utilization of oral

hypoglycemic agents in Type-2 diabetic patients. Asian J Pharm Clin

Res 2011;5:60-4.

Sultana G, Kapur P, Aqil M, Alam MS, Pillai KK. Drug utilization of

oral hypoglycemic agents in a university teaching hospital in India.

J Clin Pharm Ther 2010;35(5):267-77.

Johnson JA, Pohar SL, Secnik K, Yurgin N, Hirji Z. Utilization of

diabetes medication and cost of testing supplies in Saskatchewan, 2001.

BMC Health Serv Res 2006;6(3):159.

Sivasankari V, Manivannan E, Priyadarsini SP. Drug utilization pattern

of anti-diabetic drugs in a rural area of Tamil Nadu, South India – A

prospective, observational study. Int J Pharm Biol Sci 2013;4:514-9.

Jadhav NB, Adhav MS. Cost analysis study of oral antidiabetic drugs

available in Indian market. Int J Med Res Health Sci 2013;2(1):63-9.

Published

01-05-2016

How to Cite

Abidi, A., D. A. Rizvi, and A. Ahmad. “PHARMACOECONOMIC AND DRUG UTILIZATION STUDY OF ANTIDIABETIC THERAPY IN A TERTIARY CARE TEACHING HOSPITAL OF NORTHERN INDIA”. Asian Journal of Pharmaceutical and Clinical Research, vol. 9, no. 3, May 2016, pp. 371-5, https://mail.innovareacademics.in/journals/index.php/ajpcr/article/view/11581.

Issue

Section

Original Article(s)

Most read articles by the same author(s)